MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
3.280
-0.600 (-15.46%)
At close: Nov 2, 2026, 4:00 PM EST
3.350
+0.070 (2.13%)
After-hours: Nov 2, 2026, 7:30 PM EST
MiMedx Group Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 303.73 | 418.63 | 348.88 | 321.48 | 267.84 | 242.02 | |
Revenue Growth | -22.80% | 19.99% | 8.52% | 20.03% | 10.67% | -2.50% |
Cost of Revenue | 68.98 | 73.01 | 60.07 | 54.63 | 48.32 | 39.63 |
Gross Profit | 234.75 | 345.62 | 288.81 | 266.84 | 219.53 | 202.39 |
Selling, General & Admin | 244.4 | 266.19 | 216.39 | 216.3 | 220.85 | 198.64 |
Research & Development | 14.47 | 15.1 | 12.34 | 12.67 | 12.7 | 9.93 |
Amortization of Goodwill & Intangibles | 1.02 | 0.44 | 0.77 | 0.76 | 0.7 | 0.82 |
Operating Expenses | 259.89 | 281.73 | 229.5 | 229.73 | 234.25 | 209.39 |
Operating Income | -25.14 | 63.89 | 59.31 | 37.12 | -14.73 | -7 |
Interest Expense | -1.4 | -1.78 | -3.94 | -6.58 | -5.05 | -4.98 |
Interest & Investment Income | 4.76 | 4.72 | 2.93 | 0.12 | 0.03 | - |
Other Non Operating Income (Expenses) | -0.59 | -0.56 | -0.57 | -0.03 | -0 | -0.02 |
EBT Excluding Unusual Items | -22.38 | 66.26 | 57.74 | 30.63 | -19.75 | -12 |
Asset Writedown | - | - | -0.45 | - | - | -0.05 |
Pretax Income | -22.38 | 66.26 | 57.29 | 30.63 | -19.75 | -12.05 |
Income Tax Expense | -3.19 | 17.68 | 15.3 | -36.81 | 0.21 | 0.25 |
Earnings From Continuing Operations | -19.19 | 48.58 | 42 | 67.44 | -19.95 | -12.3 |
Earnings From Discontinued Operations | - | - | 0.42 | -9.21 | -10.24 | 2.02 |
Net Income | -19.19 | 48.58 | 42.42 | 58.23 | -30.2 | -10.29 |
Preferred Dividends & Other Adjustments | - | - | - | 11.64 | 6.58 | 6.14 |
Net Income to Common | -19.19 | 48.58 | 42.42 | 46.59 | -36.78 | -16.42 |
Net Income Growth | - | 14.52% | -8.94% | - | - | - |
Shares Outstanding (Basic) | 148 | 148 | 147 | 116 | 113 | 110 |
Shares Outstanding (Diluted) | 148 | 150 | 149 | 146 | 113 | 110 |
Shares Change | -1.32% | 0.45% | 2.11% | 29.27% | 2.32% | 1.94% |
EPS (Basic) | -0.13 | 0.33 | 0.29 | 0.40 | -0.33 | -0.15 |
EPS (Diluted) | -0.13 | 0.32 | 0.28 | 0.36 | -0.33 | -0.15 |
EPS Growth | - | 13.14% | -22.18% | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 19.12 | 72.97 | 64.51 | 24.79 | -19.41 | -5.2 |
Free Cash Flow Per Share | 0.13 | 0.49 | 0.43 | 0.17 | -0.17 | -0.05 |
Gross Margin | 77.29% | 82.56% | 82.78% | 83.00% | 81.96% | 83.63% |
Operating Margin | -8.28% | 15.26% | 17.00% | 11.54% | -5.50% | -2.89% |
Profit Margin | -6.32% | 11.60% | 12.16% | 14.49% | -13.73% | -6.78% |
Free Cash Flow Margin | 6.30% | 17.43% | 18.49% | 7.71% | -7.25% | -2.15% |
EBITDA | -17.31 | 78.77 | 65.35 | 40.54 | -10.68 | -1.82 |
EBITDA Margin | -5.70% | 18.82% | 18.73% | 12.61% | -3.99% | -0.75% |
D&A For EBITDA | 7.83 | 14.88 | 6.04 | 3.43 | 4.05 | 5.18 |
EBIT | -25.14 | 63.89 | 59.31 | 37.12 | -14.73 | -7 |
EBIT Margin | -8.28% | 15.26% | 17.00% | 11.54% | -5.50% | -2.89% |
Effective Tax Rate | - | 26.69% | 26.70% | - | - | - |
Advertising Expenses | - | 0.5 | 0.6 | 0.6 | 0.2 | 0.1 |